Investors seek to cut Pharma Bro out of his company
DealBook
July 9, 2021
FacebookTwitterEmail
FILE - In this Aug. 3, 2017, file photo, Martin Shkreli arrives at federal court in New York. A federal judge has rejected convicted Shkreli s second request to be let out of prison early, Tuesday, Jan. 19, 2021, showing skepticism about his claim in court papers that mental health issues have weakened his immune system and made him more susceptible to contracting the coronavirus. Seth Wenig/Associated Press
For years, Kevin Mulleady was an ally of Martin Shkreli s. Mulleady worked for one of the pharmaceutical executive’s hedge funds and later served as an executive at the company where Shkreli infamously raised a lifesaving drug’s price 5,000%.
How Much Longer Can Martin Shkreli Control a Pharma Firm From Prison?
nytimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nytimes.com Daily Mail and Mail on Sunday newspapers.
Opening Bell: 7 9 21
dealbreaker.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dealbreaker.com Daily Mail and Mail on Sunday newspapers.
Cytovia Therapeutics Expands Leadership Team
. announced today that Jason Aryeh, a long time biotech investor and board director, has been elected .
Segnalato da :
Cytovia Therapeutics Expands Leadership Team (Di giovedì 13 maggio 2021) . announced today that Jason Aryeh, a long time biotech investor and board director, has been elected to the
Cytovia Board of Directors, effective immediately. In addition, to support the rapid .
Leggi su padovanews